VASERETIC Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Vaseretic, and what generic alternatives are available?
Vaseretic is a drug marketed by Bausch and is included in one NDA.
The generic ingredient in VASERETIC is enalapril maleate; hydrochlorothiazide. There are twenty-seven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the enalapril maleate; hydrochlorothiazide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Vaseretic
A generic version of VASERETIC was approved as enalapril maleate; hydrochlorothiazide by TARO PHARM INDS on September 18th, 2001.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VASERETIC?
- What are the global sales for VASERETIC?
- What is Average Wholesale Price for VASERETIC?
Summary for VASERETIC
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 134 |
Patent Applications: | 3,737 |
Drug Prices: | Drug price information for VASERETIC |
What excipients (inactive ingredients) are in VASERETIC? | VASERETIC excipients list |
DailyMed Link: | VASERETIC at DailyMed |
Pharmacology for VASERETIC
Drug Class | Angiotensin Converting Enzyme Inhibitor Thiazide Diuretic |
Mechanism of Action | Angiotensin-converting Enzyme Inhibitors |
Physiological Effect | Decreased Blood Pressure Increased Diuresis |
US Patents and Regulatory Information for VASERETIC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bausch | VASERETIC | enalapril maleate; hydrochlorothiazide | TABLET;ORAL | 019221-003 | Jul 12, 1995 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Bausch | VASERETIC | enalapril maleate; hydrochlorothiazide | TABLET;ORAL | 019221-001 | Oct 31, 1986 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for VASERETIC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bausch | VASERETIC | enalapril maleate; hydrochlorothiazide | TABLET;ORAL | 019221-001 | Oct 31, 1986 | ⤷ Sign Up | ⤷ Sign Up |
Bausch | VASERETIC | enalapril maleate; hydrochlorothiazide | TABLET;ORAL | 019221-003 | Jul 12, 1995 | ⤷ Sign Up | ⤷ Sign Up |
Bausch | VASERETIC | enalapril maleate; hydrochlorothiazide | TABLET;ORAL | 019221-001 | Oct 31, 1986 | ⤷ Sign Up | ⤷ Sign Up |
Bausch | VASERETIC | enalapril maleate; hydrochlorothiazide | TABLET;ORAL | 019221-003 | Jul 12, 1995 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for VASERETIC
See the table below for patents covering VASERETIC around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
New Zealand | 192312 | CARBOXYALKYL DIPEPTIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS | ⤷ Sign Up |
Canada | 1262684 | DERIVES AMINOACIDES ASSOCIES A DES AGENTS DIURETIQUES (AMINOACID DERIVATIVES COMPOSITION IN ASSOCIATION WITH DIURETIC AGENTS) | ⤷ Sign Up |
Canada | 1275350 | LISINOPRIL (LISINOPRIL) | ⤷ Sign Up |
Spain | 8106134 | ⤷ Sign Up | |
Czechoslovakia | 237327 | METHOD OF PREPARATION OF CARBOXYALKYL DIPEPTIDE | ⤷ Sign Up |
Finland | 793799 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |